Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring its First Two
Calgary, Alberta–(Newsfile Corp. – November 26, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), is pleased to announce a binding Letter of Intent for the acquisition of the first two cardiology practices under the Company’s clinic roll-up and commercialization strategy. The practices of Dr. Roberto Manuel Fernandez-de-Castro and Dr. Hector Rosario Figueroa, two […]